809 related articles for article (PubMed ID: 10336836)
1. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):363-74. PubMed ID: 10420393
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
Sadoshima J; Izumo S
Circ Res; 1993 Sep; 73(3):413-23. PubMed ID: 8348686
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
Haddad GE; Blackwell K; Bikhazi A
Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
[TBL] [Abstract][Full Text] [Related]
6. Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
Ikeda K; Tojo K; Udagawa T; Otsubo C; Ishikawa M; Tokudome G; Hosoya T; Tajima N; Nakao K; Kawamura M
Hypertens Res; 2008 Apr; 31(4):693-706. PubMed ID: 18633182
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 and angiotensin networking in cardiac remodeling.
Rosenkranz S
Cardiovasc Res; 2004 Aug; 63(3):423-32. PubMed ID: 15276467
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+)-growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells.
Kinugawa K; Takahashi T; Kohmoto O; Yao A; Ikenouchi H; Serizawa T
Cardiovasc Res; 1995 Sep; 30(3):419-31. PubMed ID: 7585834
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
J Hypertens Suppl; 1994 Dec; 12(10):S153-7. PubMed ID: 7769485
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy.
Baker KM; Chernin MI; Schreiber T; Sanghi S; Haiderzaidi S; Booz GW; Dostal DE; Kumar R
Regul Pept; 2004 Aug; 120(1-3):5-13. PubMed ID: 15177915
[TBL] [Abstract][Full Text] [Related]
11. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Zhou DX; Liang QS; He XX; Zhan CY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Zhang SQ; Ding B; Guo ZG; Li YX
Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
[TBL] [Abstract][Full Text] [Related]
13. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Hirata Y; Kanno K; Eguchi S; Kano H
Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
Hoffmann S; Krause T; van Geel PP; Willenbrock R; Pagel I; Pinto YM; Buikema H; van Gilst WH; Lindschau C; Paul M; Inagami T; Ganten D; Urata H
J Mol Med (Berl); 2001 Oct; 79(10):601-8. PubMed ID: 11692158
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan and PD123319 on antigensin II-induced proto-oncogene expression and protein synthesis in cultured neonatal rat cardiac myocytes.
Ling Q; Guo Z; Chen T; Yu Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):283-6. PubMed ID: 9868075
[TBL] [Abstract][Full Text] [Related]
19. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
[TBL] [Abstract][Full Text] [Related]
20. How to explain the differences between renin angiotensin system modulators.
Levy BI
Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
